Validation of the GATE Software
Overview
Comparison of the differential luminance sensitivity (DLS) values at each test point
Full Title of Study: “Validation of the GATE Software for Static Visual Field Examinations”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: August 2011
Interventions
- Procedure: perimetry
- automated static perimetry with adapted GATE strategy
Arms, Groups and Cohorts
- Glaucoma
- Retinitis pigmentosa (RP)
- Anterior Ischemic Optic Neuropathy (AION)
Clinical Trial Outcome Measures
Primary Measures
- Validation of visual field data and comparison of the differential luminance sensitivity (DLS) values at each test point by applying two perimetric software versions.
- Time Frame: up to 14 days
- each participant were examined 2 times at two seperate sessions within 14 days.
Participating in This Clinical Trial
Inclusion Criteria
- physical, intellectual and linguistic abilities, in order to understand the test requirements – spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt – distant visual acuity > 10/20 – isocoria, pupil diameter > 3 mm Exclusion Criteria:
- pregnancy, nursing – diabetic retinopathy – asthma – HIV+ or AIDS – history of epilepsy or significant psychiatric disease – medications known to effect visual field sensitivity – acute ocular infections (e.g. keratitis, conjunctivitis, uveitis) – severe dry eyes – miotic drugs – amblyopia – squint – nystagmus – albinism – keratoconus – intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening – history or presence of macular disease and / or macular edema – relevant opacities of central refractive media (cornea, lens, vitreous body) – ocular trauma
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University Hospital Tuebingen
- Collaborator
- Haag-Streit AG
- Provider of Information About this Clinical Study
- Principal Investigator: Ulrich Schiefer, Prof. Dr. med. Ulrich Schiefer – University Hospital Tuebingen
- Overall Official(s)
- Ulrich Schiefer, Prof.Dr.med., Principal Investigator, University of Tuebingen, Centre for Ophthalmology
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.